Do etanercept-naive patients with rheumatoid arthritis respond better to infliximab than patients for whom etanercept has failed? [8] (multiple letters)

Annals of the Rheumatic Diseases

Volumn 63, Issue 5, 2004, Pages 607-608

  Yazici, Y ^a   Erkan, D ^b   Van Vollenhoven, R F ^c  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; INFLIXIMAB; METHOTREXATE; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANAMNESIS; CONTROLLED STUDY; DATA ANALYSIS; DRUG BIOAVAILABILITY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME;

EID: 1942436177     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)